Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity00:42

Cross-reactivity

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-destructive orientation tracking of individual β-Sn grains in die-attach solder joints.

Journal of synchrotron radiation·2026
Same author

Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia.

Annals of hematology·2026
Same author

Study on pore features in sintered die-attach microstructures based on machine learning.

Scientific reports·2026
Same author

Living sensor display implanted on skin for long-term biomarker monitoring.

Nature communications·2026
Same author

Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia.

International journal of hematology·2025
Same author

Isolation and characterization of a novel halotolerant selenate-reducing bacterium, Citrobacter koseri Y2.

Journal of bioscience and bioengineering·2025

Related Experiment Video

Updated: Jul 4, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Alpha-galactosylceramide-driven immunotherapy for allergy.

Yasuyuki Ishii1, Risa Nozawa, Yukiko Takamoto-Matsui

  • 1Laboratory for Vaccine Design, RIKEN Research Center for Allergy and Immunology, 1-7-22, Suehiro, Tsurumi, Yokohama, Kanagawa, Japan 230-0045. ishiiyas@rcai.riken.jp

Frontiers in Bioscience : a Journal and Virtual Library
|May 30, 2008
PubMed
Summary

Liposomes delivering alpha-galactosylceramide (alphaGalCer) and antigens to B cells induce regulatory T cells. This suppresses secondary antibody responses, offering a new approach to immune modulation.

More Related Videos

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: Jul 4, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Invariant natural killer T (iNKT) cells are crucial immune regulators.
  • Marginal zone B cells play a role in initiating immune responses.

Purpose of the Study:

  • To investigate the potential of alpha-galactosylceramide (alphaGalCer) and antigen co-delivery to B cells for inducing regulatory T cells.
  • To assess the impact of this approach on secondary antibody responses in mice.

Main Methods:

  • Treatment of mice with alphaGalCer-liposomes and antigenic polypeptides.
  • Co-culture of splenic B cells with iNKT cells.
  • Adoptive transfer of B cells and analysis of T cell differentiation.
  • Administration of alphaGalCer-OVA-liposomes and assessment of immune suppression.

Main Results:

  • Liposomal alphaGalCer, but not aqueous form, induced IL-10 production in B cells co-cultured with iNKT cells.
  • Adoptive transfer of these B cells promoted the differentiation of regulatory T cells (CD4+ CD25high Foxp3+).
  • In vivo administration of alphaGalCer-OVA-liposomes generated IL-10 and IFN-gamma producing T cells, suppressing antigen-specific secondary antibody responses.

Conclusions:

  • Antigen-containing alphaGalCer-liposomes can induce tolerogenic antigen-presenting cells and regulatory T cells.
  • This strategy effectively suppresses immune responses, suggesting therapeutic potential for autoimmune diseases and transplantation.